HM Payson & Co. trimmed its position in ImmuCell Co. (NASDAQ:ICCC – Free Report) by 50.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,000 shares of the biotechnology company’s stock after selling 6,130 shares during the quarter. HM […]
HM Payson & Co. lowered its position in ImmuCell Co. (NASDAQ:ICCC – Free Report) by 50.5% during the 3rd quarter, Holdings Channel reports. The firm owned 6,000 shares of the biotechnology company’s stock after selling 6,130 shares during the quarter. HM Payson & Co.’s holdings in ImmuCell were worth $31,000 at the end of the […]
Shares of ImmuCell Co. (NASDAQ:ICCC – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $5.12 and traded as low as $4.56. ImmuCell shares last traded at $4.62, with a volume of 22,230 shares changing hands. ImmuCell Stock Down 2.0 % The […]
ImmuCell (NASDAQ:ICCC – Get Free Report) posted its earnings results on Monday. The biotechnology company reported ($0.12) EPS for the quarter, reports. ImmuCell had a negative return on equity of 22.14% and a negative net margin of 38.70%. The business had revenue of $5.40 million for the quarter. ImmuCell Stock Performance Shares of NASDAQ ICCC […]
ImmuCell Co. (NASDAQ:ICCC – Get Free Report) was the target of a significant decline in short interest in October. As of October 15th, there was short interest totalling 8,000 shares, a decline of 28.6% from the September 30th total of 11,200 shares. Currently, 0.1% of the shares of the stock are short sold. Based on […]